FDA

FDA Statement

OxyHealth chambers are Class 2 medical devices, which require a prescription from a licensed physician. As indicated in our FDA 510(K) clearance, all of our chambers are approved for clinic and home use.

13 FDA Indications for HBOT

  1. Air or Gas Embolism
  2. Acute Carbon Monoxide Poisoning
  3. Gas Gangrene
  4. Crush Injury
  5. Decompression Sickness
  6. Enhancement of Healing in Selected Problem Wounds
  7. Exceptional Blood Loss (Anemia)
  8. Intracranial Abscess
  9. Necrotizing Soft Tissue Infections
  10. Osteomyelitis
  11. Delayed Radiation Injury
  12. Compromised Skin Grafts & Flaps
  13. Thermal Burns

FDA regulations require that the chambers be sold to or on the order of a STATE licensed practitioner.

REGULATORY UPDATE

OxyHealth, LLC Pursuant to FDA Warning Letter #406207, OxyHealth has always maintained 510(k) clearance and approval from the FDA to market and retail portable hyperbaric chambers to the public at large, since its inception. No violation was present and no corrective actions were taken, as OxyHealth invariably sustains legal and ethical business practices to ensure lawful amenability towards consumer compliance in accordance with FDA rules and regulations.